Michele Merritt is VP, Commercial Development for Quantgene, a start-up company focused in biotechnology, liquid biopsy and early cancer detection. She had many years of experience in sales and launching disruptive products with physicians, health systems and lab partnerships.
She holds a Bachelors degree in Speech Communications and a Minor in Spanish from the University of Illinois, 1992. She is working with Quantgene at launching the first early detection liquid biopsy test for the U.S; and is developing the company and early cancer detection test to become globally well-known. She is passionate about patients, catching cancer early and has a willingness to learn new things and grow more every day. She is determined to change healthcare for the better.
On the horizon, she plans to stay where she currently is now, and use the growth and experience she has been through to get to where she is now. Michele is also a member of AdvisoryCloud, https://www.advisorycloud.com/profile/Michele-Merritt, and can help you with any sales or product launch needs in a consulting format. She is looking forward to networking and connecting with other like-minded professionals, and to gaining the recognition and credibility of being a member.
Worldwide Association of Female Professionals Member, Michele Merritt, can be found on the Association Directory, where she is looking forward to networking with you.